Stockscreener 앱 받기
67.65
0.21%
0.19
전일 마감가:
$67.46
열려 있는:
$68.23
하루 거래량:
4.79M
Relative Volume:
0.48
시가총액:
$81.97B
수익:
$378.96B
순이익/손실:
$5.28B
주가수익비율:
16.15
EPS:
4.19
순현금흐름:
$5.94B
1주 성능:
+4.12%
1개월 성능:
+6.20%
6개월 성능:
+22.16%
1년 성능:
+20.94%
1일 변동 폭
$67.36
$68.28
1주일 범위
$64.42
$72.51
52주 변동 폭
$43.56
$72.51
CVS헬스 Stock (CVS) Company Profile
명칭
Cvs Health Corp
전화
(401) 765-1500
주소
ONE CVS DR., WOONSOCKET
CVS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
67.65 | 81.97B | 378.96B | 5.28B | 5.94B | 4.19 |
|
UNH
Unitedhealth Group Inc
|
408.87 | 382.29B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
416.63 | 93.50B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CI
Cigna Group
|
333.74 | 90.77B | 244.38B | 3.43B | 8.96B | 12.24 |
|
HUM
Humana Inc
|
259.28 | 31.77B | 117.76B | 1.21B | 2.39B | 9.95 |
CVS헬스 Stock (CVS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-13 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | 업그레이드 | Edward Jones | Hold → Buy |
| 2024-12-03 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-11-18 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-10-04 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-05-30 | 개시 | Robert W. Baird | Neutral |
| 2024-05-07 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-05-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-05-01 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | 개시 | Barclays | Equal Weight |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2023-12-22 | 개시 | HSBC Securities | Buy |
| 2023-09-19 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-09-12 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | 다운그레이드 | Edward Jones | Buy → Hold |
| 2023-05-26 | 개시 | Piper Sandler | Overweight |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 재개 | Morgan Stanley | Overweight |
| 2022-06-17 | 개시 | Loop Capital | Buy |
| 2022-05-27 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-02-11 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | 개시 | Goldman | Buy |
| 2021-12-01 | 개시 | Seaport Research Partners | Buy |
| 2021-05-19 | 개시 | Wells Fargo | Equal Weight |
| 2021-03-17 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-01-08 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-09-17 | 개시 | Piper Sandler | Overweight |
| 2020-07-01 | 개시 | SVB Leerink | Mkt Perform |
| 2020-05-14 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | 재개 | RBC Capital Mkts | Outperform |
| 2019-09-12 | 개시 | Deutsche Bank | Buy |
| 2019-06-05 | 업그레이드 | Standpoint Research | Hold → Buy |
| 2019-04-29 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | 개시 | Guggenheim | Buy |
| 2019-04-15 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2019-04-10 | 재확인 | BofA/Merrill | Buy |
| 2019-03-13 | 개시 | Bernstein | Outperform |
| 2019-02-20 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | 개시 | UBS | Buy |
| 2018-12-18 | 개시 | Barclays | Overweight |
| 2018-11-29 | 재개 | Goldman | Neutral |
| 2018-11-28 | 개시 | Evercore ISI | Outperform |
| 2018-10-26 | 재개 | Wolfe Research | Peer Perform |
| 2018-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-02-27 | 재개 | BofA/Merrill | Buy |
| 2018-02-13 | 재확인 | Citigroup | Neutral |
모두보기
CVS헬스 주식(CVS)의 최신 뉴스
RBC Capital Raises Price Target for CVS Health to $81 | CVS Stock News - GuruFocus
RBC Capital Boosts Price Target for CVS to $81 Following Q1 Results | CVS Stock News - GuruFocus
CVS Health (CVS) Price Target Boosted by Analyst Following Positive Outlook | CVS Stock News - GuruFocus
Comerica Bank Reduces Stock Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS (CVS) Embarks on Strategic Shift Amidst Health Sector Challenges - GuruFocus
2 Healthcare Stocks to Research Further and 1 to Be Wary Of - The Globe and Mail
Stocktwits Spotlight: NRx, CVS, ReShape Lead Weekly Jump In Health Care Stock Chatter - Investing.com India
One68 Global Capital LLC Acquires Shares of 80,597 CVS Health Co. (NYSE:CVS) - MarketBeat
8 Knots Management LLC Decreases Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
Is CVS Health Corporation (CVS) The Best Stock To Buy and Hold For 10 Years? - Insider Monkey
CVS Health (CVS) Exceeds Earnings Expectations, Analysts Maintain Revenue Forecasts - GuruFocus
CVS Health rides improving Medicare business to better-than-expected first quarter - LancasterOnline
CVS Health (CVS) Exceeds Q1 Expectations with Revenue and EPS Gains - GuruFocus
12 Best Stocks to Buy and Hold For 10 Years - Insider Monkey
CVS Health Corporation (NYSE:CVS) Q1 2025 Earnings Call Transcript - Insider Monkey
Whitebox Advisors LLC Acquires New Shares in CVS Health Co. (NYSE:CVS) - MarketBeat
Freestone Grove Partners LP Buys Shares of 806,575 CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Rides Improving Medicare Business In First Quarter - Post Journal
UBS Raises Price Target for CVS Health (CVS) to $71 | CVS Stock News - GuruFocus
CVS Health Stock Price | CVS Stock Quote, News, and History - markets.businessinsider.com
A Glimpse Into The Expert Outlook On CVS Health Through 10 Analysts - Benzinga
CVS (CVS) Shows Resilience with Solid Earnings Amid Healthcare Shifts - GuruFocus
CVS makes deal to make popular weight loss drug cheaper - TheStreet
CVS Health Raises Forecast After Strong Q1 Results - Finimize
Health Insurance Market Size to Lead USD 5,190 Bn by 2034 Rising chronic diseases and healthcare costs are fueling demand for coverage - GlobeNewswire Inc.
CVS Health (CVS) Target Price Raised to $82 by Barclays | CVS Stock News - GuruFocus
CVS reports strong Q1 earnings, will exit Aetna’s ACA plans - InsuranceNewsNet
Eli Lilly Tackles CVS Health's Cut In Zepbound Coverage - Finimize
CVS Decision Sparks Reaction in Market, Impact on Eli Lilly Anal - GuruFocus
CVS Health (CVS) Target Price Upped by BofA Amid Positive Outloo - GuruFocus
CVS Decision Sparks Reaction in Market, Impact on Eli Lilly Analyzed | CVS Stock News - GuruFocus
CVS Health (CVS) Target Price Upped by BofA Amid Positive Outlook | CVS Stock News - GuruFocus
CVS Health (CVS) Gains After Surpassing Earnings Estimates and S - GuruFocus
Northern Trust Corp Has $560.76 Million Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
Decoding CVS Health Corp (CVS): A Strategic SWOT Insight - GuruFocus
CVS (CVS) Faces DOJ Allegations of Discriminatory Practices - GuruFocus
CVS Health Corp (CVS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
CVS Health Reports Strong Q1 2025 Results - TipRanks
What Are Wall Street Analysts' Target Price for CVS Health Stock? - MSN
Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge - Reuters
CVS Health’s Q1 2025 Earnings Call: Strong Results and Optimistic Outlook - TipRanks
Obesity Drug Price Wars Heating Up as CVS Picks Novo Over Lilly - Bloomberg.com
DOJ sues insurers over alleged Medicare Advantage kickbacks - Modern Healthcare
Zepbound Grows, But CVS/Novo Nordisk Deal For Wegovy Casts Shadow - insights.citeline.com
CVS Caremark to Place Wegovy as Preferred GLP-1 for Weight Loss - Managed Healthcare Executive
US accuses health insurers, brokers of Medicare Advantage kickback scheme - Reuters
CVS Health raises annual profit forecast as turnaround gathers steam - MSN
CVS Drops Lilly’s Zepbound from Preferred Coverage in Novo Win - Bloomberg.com
Oxford Asset Management LLP Raises Stock Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge By Reuters - Investing.com
CVS Faces Legal Action Over Alleged Medicare Advantage Kickbacks | CVS Stock News - GuruFocus
CVS헬스 (CVS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.45%
1.46%
자본화:
|
볼륨(24시간):